DK1439832T3 - Fremgangsmåde til behandling af acne vulgaris ved anvendelse af en avermectinforbindelse - Google Patents

Fremgangsmåde til behandling af acne vulgaris ved anvendelse af en avermectinforbindelse

Info

Publication number
DK1439832T3
DK1439832T3 DK02768995T DK02768995T DK1439832T3 DK 1439832 T3 DK1439832 T3 DK 1439832T3 DK 02768995 T DK02768995 T DK 02768995T DK 02768995 T DK02768995 T DK 02768995T DK 1439832 T3 DK1439832 T3 DK 1439832T3
Authority
DK
Denmark
Prior art keywords
acne vulgaris
treating acne
avermectin compound
dermatological composition
avermectin
Prior art date
Application number
DK02768995T
Other languages
English (en)
Inventor
L Dean Parks
Original Assignee
L Dean Parks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/976,915 external-priority patent/US6399651B1/en
Application filed by L Dean Parks filed Critical L Dean Parks
Application granted granted Critical
Publication of DK1439832T3 publication Critical patent/DK1439832T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
DK02768995T 2001-10-12 2002-10-03 Fremgangsmåde til behandling af acne vulgaris ved anvendelse af en avermectinforbindelse DK1439832T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/976,915 US6399651B1 (en) 2000-06-29 2001-10-12 Method of treating dermatoses using avermectin compound
US09/988,914 US6399652B1 (en) 2000-06-29 2001-11-19 Method of treating acne vulgaris using avermectin compound
PCT/US2002/032002 WO2003032977A1 (en) 2001-10-12 2002-10-03 Method of treating acne vulgaris using avermectin compound

Publications (1)

Publication Number Publication Date
DK1439832T3 true DK1439832T3 (da) 2007-05-21

Family

ID=27130590

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02768995T DK1439832T3 (da) 2001-10-12 2002-10-03 Fremgangsmåde til behandling af acne vulgaris ved anvendelse af en avermectinforbindelse

Country Status (8)

Country Link
US (1) US6399652B1 (da)
EP (1) EP1439832B1 (da)
AT (1) ATE355058T1 (da)
CY (1) CY1106604T1 (da)
DE (1) DE60218508T2 (da)
DK (1) DK1439832T3 (da)
ES (1) ES2280572T3 (da)
WO (1) WO2003032977A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
AU2004231323C1 (en) 2003-04-24 2016-11-03 Galderma Holding SA Topical formulation of ivermectin for the treatment of dermatological conditions
US20050031699A1 (en) * 2003-06-26 2005-02-10 L'oreal Porous particles loaded with cosmetically or pharmaceutically active compounds
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
DE602005020912D1 (de) 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme
FR2886850B1 (fr) * 2005-06-10 2007-10-05 Galderma Sa Composition a base d'une avermectine et de peroxyde de benzoyle notamment pour le traitement de la rosacee
FR2886852B1 (fr) * 2005-06-10 2007-11-23 Galderma Sa Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
FR2886851B1 (fr) * 2005-06-10 2007-10-05 Galderma Sa Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
US20070196292A1 (en) * 2005-11-30 2007-08-23 Robinson Larry R Personal care composition comprising dehydroacetate salts
FR2894823B1 (fr) * 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
FR2906467B1 (fr) * 2006-09-28 2012-11-09 Galderma Sa Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
EP2091325B1 (en) 2006-10-12 2014-08-06 Topaz Pharmaceuticals Inc. Shampoo-conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment-resistant strains of lice
US8901163B2 (en) * 2007-01-03 2014-12-02 Galderma S.A. Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
EP2629770B1 (en) 2010-10-20 2016-05-25 Galderma S.A. Ivermectin for use in treating otitis externa
US8912151B2 (en) 2010-10-20 2014-12-16 Galderma S.A. Method of treating hemorrhoids using macrocyclic lactone compound
US9233117B2 (en) 2013-07-08 2016-01-12 Galderma S. A. Treatment of inflammatory lesions of rosacea with ivermectin
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
WO2015144907A1 (fr) 2014-03-28 2015-10-01 Galderma Research & Development Mousse chimique non rincée contenant du peroxyde de benzoyle
FR3028763A1 (fr) * 2014-11-20 2016-05-27 Galderma Sa Compositions comprenant un compose de la famille des avermectines et un compose antagoniste d'au moins un des recepteurs rar pour le traitement de l'acne
US10653659B2 (en) * 2014-11-20 2020-05-19 Galderma S.A. Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne
FR3041541B1 (fr) * 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee comprenant de l'ivermectine
FR3041538B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041536B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne.
FR3041537B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant de la brimonidine et son utilisation dans le traitement de la rosacee.
FR3041535B1 (fr) 2015-09-29 2019-01-25 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
FR3041539B1 (fr) 2015-09-29 2018-10-26 Galderma Research & Development Composition nettoyante auto-moussante contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041540B1 (fr) * 2015-09-29 2018-10-26 Galderma Research & Development Composition nettoyante auto-moussante a rincer, contenant de l'ivermectine.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439924A (en) * 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
US5654312A (en) * 1995-06-07 1997-08-05 Andrulis Pharmaceuticals Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
ES2319699T3 (es) * 1996-05-20 2009-05-11 Otsuka Pharmaceutical Co., Ltd. Remedio para la rosacea.
CN1142776C (zh) * 1996-06-11 2004-03-24 曾田香料株式会社 抗菌剂及使用它的化妆品以及衣料
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US20030064940A1 (en) * 2001-10-02 2003-04-03 Parks L. Dean Kit for treating acne vulgaris using avermectin compound

Also Published As

Publication number Publication date
US20020061855A1 (en) 2002-05-23
EP1439832A1 (en) 2004-07-28
DE60218508D1 (de) 2007-04-12
EP1439832B1 (en) 2007-02-28
US6399652B1 (en) 2002-06-04
EP1439832A4 (en) 2005-01-05
WO2003032977A1 (en) 2003-04-24
DE60218508T2 (de) 2007-11-08
CY1106604T1 (el) 2012-01-25
ES2280572T3 (es) 2007-09-16
ATE355058T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
DK1439832T3 (da) Fremgangsmåde til behandling af acne vulgaris ved anvendelse af en avermectinforbindelse
CA2488405A1 (en) Sebum and perspiration absorption foundation kit and associated multi-step method
HK1043942A1 (en) Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
WO2003105787A3 (en) MULTIPLE STEPS AND ASSOCIATED COSMETIC FOUNDATION KIT
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
AU2001253038A1 (en) Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
BR9503559A (pt) Composição cosmeticamente aceitável processo para o tratamento de acne vulgaris composição para maquiagem facial
WO2000027381A3 (en) Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
CA2397198A1 (en) Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions
WO2004093722A3 (en) Topical treatment of dermatological disorders associated with reactive or dilated blood vessels
TW200505473A (en) Compositions and methods for treatment of psoriasis
PT1390007E (pt) Composição cosmética à base de sucralfato e de sulfatos de cobre e de zinco
BR0115389A (pt) Composição cosmética, método cosmético e uso de composição tópica
EP1465577A4 (en) METHODS FOR ENHANCING THE AESTHETIC ASPECT OF THE SKIN
WO2004103353A3 (en) Topical treatment of sebum related skin conditions
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
ATE554757T1 (de) Verwendung von mindestens einem 2-alkyl-furan als wirkstoff zur depigmentierung oder aufhellung
BRPI0414850A (pt) uso tópico de derivados de ácido halossalicìlico
WO2004103321A3 (en) Topical treatment of ingrown hairs
CA2421026A1 (en) Viral inhibition by n-docosanol
WO2002041866A3 (en) Cosmetic composition
SE9904059D0 (sv) Serine protease and topical retinoid compositions
TW200701990A (en) Composition for improving an area of skin hydration and method thereof
CA2421721A1 (en) Therapeutic topical solution for skin and associated methods of use
DK1247521T3 (da) Anvendelse af biguanid- og pyrimidin-derivater til fremstilling af topiske hudplejetilberedninger